27 results
8-K
EX-2.1
MACA
Moringa Acquisition Corp - Ordinary Shares
3 Apr 24
Entry into a Material Definitive Agreement
11:22am
has unfunded liabilities that will not be offset by insurance or that are not fully accrued on the Financial Statements; and (viii) the consummation
8-K
EX-2.1
MACA
Moringa Acquisition Corp - Ordinary Shares
26 Feb 24
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
5:29pm
to the Group Companies taken as a whole; (vii) no Foreign Plan has unfunded liabilities that will not be offset by insurance or that are not fully
425
EX-10.4.6
jz6o4aa42ml1hzic
13 Jun 22
Business combination disclosure
5:15pm
8-K
EX-10.4.6
vkxc5u
13 Jun 22
There’s always a better travel deal out there INVESTOR PRESENTATION JUNE 2022
5:12pm
10-Q
hx0xmjhtpt1 ot17o06o
25 May 21
Quarterly report
5:06pm
10-K
8hzxznbqg ehl6754r
31 Mar 21
Annual report
5:15pm
8-K
EX-10.8
53woz0yov
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.12
6y3m hag97pt
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.9
7r16damht
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.11
3bcz8pg7ighl3m
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm